These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 6748496

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical, cardio- and hemodynamic effects of long- and short-acting beta-adrenergic blockers in the treatment of patients with stable stenocardia].
    Ol'binskaia LI, Bragina GI.
    Kardiologiia; 1984 Apr; 24(4):9-13. PubMed ID: 6727119
    [Abstract] [Full Text] [Related]

  • 24. [Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic].
    Gel'fgat EB, Muradova SA, Iagizarova NM, Abdullaeva IA.
    Kardiologiia; 1988 Oct; 28(10):47-51. PubMed ID: 3147339
    [Abstract] [Full Text] [Related]

  • 25. [Evaluation of obzidan efficacy in patients with unstable stenocardia].
    Gvatua NA, SHumakov VA, Tashchuk VK, Malinovskaia IE, Pliska AI.
    Ter Arkh; 1989 Oct; 61(8):21-4. PubMed ID: 2588162
    [Abstract] [Full Text] [Related]

  • 26. [Anti-angina effectiveness of sustak and obzidan in the acute period of myocardial infarct].
    Kavtaradze VG, Iosava KV, Machavariani PT, Kveselava MV.
    Kardiologiia; 1980 Nov; 20(11):84-6. PubMed ID: 6777576
    [Abstract] [Full Text] [Related]

  • 27. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W, Fluch N, Brandt D.
    Wien Klin Wochenschr; 1982 May 14; 94(10):258-61. PubMed ID: 6126961
    [Abstract] [Full Text] [Related]

  • 28. [Treatment of patients with stable angina by combination of trinitrolong and propranolol].
    Kukushkin SK, Metelitsa VI, Kokurina EV, Bochkarëva EV.
    Klin Med (Mosk); 1993 May 14; 71(5):30-3. PubMed ID: 8301980
    [Abstract] [Full Text] [Related]

  • 29. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina.
    Saito T, Fujii K, Takizawa T, Toyosaki T, Kuwabara Y, Kobayashi S, Ichikawa H, Karaki A, Yamazaki Y, Iwata J, Yamada K, Tomiya H, Takeda K, Inagaki Y.
    Arzneimittelforschung; 1996 Sep 14; 46(9):861-7. PubMed ID: 8876934
    [Abstract] [Full Text] [Related]

  • 30. [Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
    Korabel'shchikova NI, Rishko NV, Bichko MV.
    Vrach Delo; 1985 Aug 14; (8):19-21. PubMed ID: 3840931
    [No Abstract] [Full Text] [Related]

  • 31. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS, Comerford MB, Sowton E.
    J Int Med Res; 1976 Aug 14; 4(1):15-22. PubMed ID: 799974
    [Abstract] [Full Text] [Related]

  • 32. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK, Zaĭtseva VI.
    Ter Arkh; 1987 Aug 14; 59(9):120-2. PubMed ID: 3424175
    [No Abstract] [Full Text] [Related]

  • 33. [Propranolol treatment of effort angina in patients with arterial hypotension].
    Idrisova EM, Boshchenko AA, Borovkova NV, Demochko AV, Chernov VI, Karpov RS.
    Ter Arkh; 2004 Aug 14; 76(8):32-6. PubMed ID: 15471393
    [Abstract] [Full Text] [Related]

  • 34. The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
    Piatak OA, Yanovskii GV, Lizogub VG.
    Cor Vasa; 1991 Aug 14; 33(1):19-25. PubMed ID: 1655353
    [Abstract] [Full Text] [Related]

  • 35. [Diagnostic and treatment characteristics of ischemic heart disease patients with asynergies].
    Furkalo NK, Lutaĭ MI, Zaĭtseva VI.
    Ter Arkh; 1985 Aug 14; 57(9):34-7. PubMed ID: 4082046
    [Abstract] [Full Text] [Related]

  • 36. [Methodological approaches to assessing the effectiveness of anti-angina preparations in stenocardia patients using paired bicycle ergometry loads].
    Kokurina EV, Bochkareva EV, Martsevich SIu, Shakarova SSh, Vygodin VA.
    Kardiologiia; 1985 Apr 14; 25(4):35-40. PubMed ID: 4021271
    [Abstract] [Full Text] [Related]

  • 37. [Evaluation of the anti-anginal activity of diltiazem during prolonged administration in subjects with exertional angina. Cross-over double-blind study in comparison with propranolol].
    Novo S, Adamo L, Strano A.
    Cardiologia; 1985 Dec 14; 30(12):1153-62. PubMed ID: 3842651
    [No Abstract] [Full Text] [Related]

  • 38. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.
    Miller RR, Olson HG, Amsterdam EA, Mason DT.
    N Engl J Med; 1975 Aug 28; 293(9):416-8. PubMed ID: 1097925
    [Abstract] [Full Text] [Related]

  • 39. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS, Tweddel AC, Murray RG, Lawrie TD.
    Arzneimittelforschung; 1980 Aug 28; 30(9):1595-9. PubMed ID: 7006619
    [Abstract] [Full Text] [Related]

  • 40. [Ergometry as a method of evaluation of antianginal drugs].
    Piña López-Yllana C.
    Arch Farmacol Toxicol; 1979 Dec 28; 5(3):231-4. PubMed ID: 546345
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.